Energenesis Biomedical CO.,LTD. (6657.TW)

TWD 58.3

(2.1%)

Revenue Summary of Energenesis Biomedical CO.,LTD.

  • Energenesis Biomedical CO.,LTD.'s latest annual revenue in 2023 was 7.15 Million TWD , down -2.63% from previous year.
  • Energenesis Biomedical CO.,LTD.'s latest quarterly revenue in 2024 Q2 was 1.63 Million TWD , up 15.77% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported a annual revenue of 7.35 Million TWD in annual revenue 2022, down -1.84% from previous year.
  • Energenesis Biomedical CO.,LTD. reported a annual revenue of 7.48 Million TWD in annual revenue 2021, up 5.76% from previous year.
  • Energenesis Biomedical CO.,LTD. reported a quarterly revenue of 1.4 Million TWD for 2024 Q1, down -37.0% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported a quarterly revenue of 1.54 Million TWD for 2023 Q1, down -37.93% from previous quarter.

Annual Revenue Chart of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Historical Annual Revenue of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Year Revenue Revenue Growth
2023 7.15 Million TWD -2.63%
2022 7.35 Million TWD -1.84%
2021 7.48 Million TWD 5.76%
2020 7.08 Million TWD 13.28%
2019 6.25 Million TWD 0.0%

Peer Revenue Comparison of Energenesis Biomedical CO.,LTD.

Name Revenue Revenue Difference
Apex Biotechnology Corp. 1.67 Billion TWD 99.573%
Sinphar Pharmaceutical Co.,Ltd. 2.96 Billion TWD 99.758%
Panion & Bf Biotech Inc. 1.88 Billion TWD 99.62%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 2.08 Billion TWD 99.657%
GenMont Biotech Incorporation 318.01 Million TWD 97.749%
Abnova (Taiwan) Corporation 382.05 Million TWD 98.126%
Adimmune Corporation 1.78 Billion TWD 99.599%
Tanvex BioPharma, Inc. 61.41 Million TWD 88.344%
Polaris Group 7.48 Million TWD 4.318%
UnicoCell Biomed Co., Ltd. 24.58 Million TWD 70.889%
PELL Bio-Med Technology Co. Ltd. 18.03 Million TWD 60.306%